Literature DB >> 15358134

Neuroglycan C, a novel member of the neuregulin family.

Yumi Kinugasa1, Hiroshi Ishiguro, Yoshihito Tokita, Atsuhiko Oohira, Hiroshi Ohmoto, Shigeki Higashiyama.   

Abstract

Neuroglycan C (NGC) is a transmembrane chondroitin sulfate proteoglycan expressed predominantly in the brain that possesses an EGF-like extracellular domain. The goal of the present study was to determine whether NGC may activate ErbB tyrosine kinases. A recombinant human NGC extracellular domain induced tyrosine phosphorylation of ErbB2 and ErbB3 as well as cell growth of the human breast tumor cell lines, T47D and MDA-MB-453. In vitro pull-down assay revealed that NGC could directly bind to a recombinant ErbB3-immunoglobulin Fc fusion protein (ErbB3-Fc) but not to ErbB1-Fc, ErbB2-Fc or ErbB4-Fc. A newly established anti-ErbB3 neutralizing monoclonal antibody (#5C3) almost completely blocked NGC-induced ErbB activation in MDA-MB-453 cells. Taken together, these data indicate that NGC is an active growth factor and a direct ligand for ErbB3 and that NGC transactivates ErbB2. Thus, NGC should be classified as the sixth member (neuregulin-6) of the neuregulin family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358134     DOI: 10.1016/j.bbrc.2004.07.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.

Authors:  Arezu Jahani-Asl; Cheng Cheng; Chi Zhang; Azad Bonni
Journal:  Neurobiol Dis       Date:  2016-09-12       Impact factor: 5.996

Review 2.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

3.  ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.

Authors:  Anupama Sathyamurthy; Dong-Min Yin; Arnab Barik; Chengyong Shen; Jonathan C Bean; Dwight Figueiredo; Jin-Xiong She; Wen-Cheng Xiong; Lin Mei
Journal:  Development       Date:  2015-01-06       Impact factor: 6.868

Review 4.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Authors:  Miranda L Fisher; Anu Loukola; Jaakko Kaprio; Jill R Turner
Journal:  Int Rev Neurobiol       Date:  2015-09-16       Impact factor: 3.230

5.  Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.

Authors:  Joshua Z Press; Kaitlyn Wurz; Barbara M Norquist; Ming K Lee; Christopher Pennil; Rochelle Garcia; Piri Welcsh; Barbara A Goff; Elizabeth M Swisher
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

6.  The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain.

Authors:  Chi Zhang; Luis A Mejia; Ju Huang; Pamela Valnegri; Eric J Bennett; Julius Anckar; Arezu Jahani-Asl; Gilbert Gallardo; Yoshiho Ikeuchi; Tomoko Yamada; Michael Rudnicki; J Wade Harper; Azad Bonni
Journal:  Neuron       Date:  2013-06-19       Impact factor: 17.173

Review 7.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 8.  Functional selectivity of EGF family peptide growth factors: implications for cancer.

Authors:  Kristy J Wilson; Jennifer L Gilmore; John Foley; Mark A Lemmon; David J Riese
Journal:  Pharmacol Ther       Date:  2008-12-16       Impact factor: 12.310

Review 9.  The neuregulin family of genes and their multiple splice variants in breast cancer.

Authors:  Nandini V L Hayes; William J Gullick
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-15       Impact factor: 2.673

10.  Inter-conversion of neuregulin2 full and partial agonists for ErbB4.

Authors:  Kristy J Wilson; Christopher P Mill; Elizabeth M Cameron; Stuart S Hobbs; Robert P Hammer; David J Riese
Journal:  Biochem Biophys Res Commun       Date:  2007-10-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.